| Income Statement |
| Total Revenue | 7.85M |
|
| Revenues (USD) | 7.85M |
| Cost of Revenue | 5.82M |
| Gross Profit | 2.03M |
| Operating Expenses | 1.75M |
| Research and Development Expense | 94.06K |
| Selling, General and Administrative Expense | 1.65M |
| Operating Income | 286.58K |
| Interest Expense | 113.05K |
| Income Tax Expense | 52.41K |
| Net Income | 173.48K |
| Net Income Common Stock | 173.48K |
| Net Income Common Stock (USD) | 173.48K |
| Consolidated Income | 173.48K |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 338.93K |
| Earning Before Interest & Taxes (USD) | 338.93K |
| Weighted Average Shares | 5.19M |
| Weighted Average Shares Diluted | 5.19M |
| Balance Sheet |
| Cash and Equivalents | 5.97K |
| Cash and Equivalents (USD) | 5.97K |
| Trade and Non-Trade Receivables | 3.56M |
| Current Assets | 16.02M |
| Property, Plant & Equipment Net | 5.24M |
| Total Assets | 23.68M |
| Debt Current | 4.07M |
| Total Debt | 6.55M |
| Current Liabilities | 7.39M |
| Debt Non-Current | 2.48M |
| Total Liabilities | 9.87M |
| Accumulated Retained Earnings (Deficit) | 8.73M |
| Shareholders Equity | 13.80M |
| Shareholders Equity (USD) | 13.80M |
| Assets Non-Current | 7.66M |
| Total Debt (USD) | 6.55M |
| Deferred Revenue | 529.45K |
| Deposit Liabilities | 175.14K |
| Inventory | 11.50M |
| Liabilities Non-Current | 2.48M |
| Trade and Non-Trade Payables | 1.51M |
| Tax Assets | 1.95M |
| Tax Liabilities | 15.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 205.13K |
| Net Cash Flow from Financing | -100.51K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.03K |
| Capital Expenditure | -258.48K |
| Issuance (Purchase) of Equity Shares | -1.69K |
| Issuance (Repayment) of Debt Securities | -98.81K |
| Net Cash Flow from Investing | -258.48K |
| Net Cash Flow from Operations | 362.01K |
| Share Based Compensation | 86.81K |